Related references
Note: Only part of the references are listed.
Letter
Rheumatology
Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'
Elisa Gremese et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Review
Rheumatology
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
Shintaro Akiyama et al.
Summary: Patients with autoimmune diseases have a higher risk of COVID-19, primarily due to glucocorticoid use. Monotherapy with b/tsDMARDs is associated with a lower risk of hospitalisation and death.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Letter
Rheumatology
Pulmonary intravascular coagulopathy in COVID-19 pneumonia
Giovanni Brondani et al.
LANCET RHEUMATOLOGY (2020)
Share Paper
